Skip to main content

Table 5 Summary of the impact of each treatment scenario at 2020

From: Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality

2020 outcomes

Total HCV cases

HCV-related fibrosis

HCV-related cirrhosis

HCV-related decompensated cirrhosis

HCV-related HCC

HCV-related liver related deaths

Base case

122000

107000

12600

1140

640

570

(80300 – 153000)

(69900 – 138000)

(5560 – 20600)

(470 – 2050)

(320 – 1180)

(260–970)

Increasing diagnosis and treatment

89400

83500

4850

410

310

280

(52300 – 122000)

(48900 – 116000)

(2050 – 10400)

(160 – 980)

(140 – 700)

(120 – 600)